Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$3.09 - $6.0 $209,869 - $407,514
67,919 Added 85.99%
146,901 $785,000
Q4 2023

Jan 24, 2024

SELL
$1.57 - $4.58 $265,160 - $773,525
-168,892 Reduced 68.14%
78,982 $337,000
Q3 2023

Oct 26, 2023

BUY
$3.14 - $11.2 $82,845 - $295,500
26,384 Added 11.91%
247,874 $971,000
Q2 2023

Aug 10, 2023

BUY
$8.45 - $12.48 $541,560 - $799,843
64,090 Added 40.72%
221,490 $2.24 Million
Q1 2023

May 04, 2023

BUY
$9.21 - $14.98 $88,498 - $143,942
9,609 Added 6.5%
157,400 $1.61 Million
Q4 2022

Feb 09, 2023

SELL
$8.57 - $17.0 $369,718 - $733,397
-43,141 Reduced 22.59%
147,791 $1.38 Million
Q3 2022

Nov 10, 2022

BUY
$12.56 - $17.54 $311,035 - $434,360
24,764 Added 14.9%
190,932 $2.78 Million
Q2 2022

Jul 26, 2022

BUY
$10.55 - $18.81 $1 Million - $1.79 Million
95,062 Added 133.69%
166,168 $2.19 Million
Q1 2022

Jun 02, 2022

BUY
$11.67 - $26.72 $829,807 - $1.9 Million
71,106 New
71,106 $1.21 Million
Q1 2022

May 10, 2022

SELL
$11.67 - $26.72 $1.01 Million - $2.31 Million
-86,621 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$13.77 - $42.56 $1.19 Million - $3.69 Million
86,621 New
86,621 $2.22 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.